Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989454240> ?p ?o ?g. }
- W1989454240 endingPage "482" @default.
- W1989454240 startingPage "457" @default.
- W1989454240 abstract "From the heterogeneous group ofhypoplastic-aplastic anemias, several well-defined clinical and hematological entities and distinctive blood responses have been chosen for review. These are normochromic and normocytic syndromes differentiated from other blood dyscrasias by the absence of active blood formation and their resistance to all forms of antianemia treatment except transfusion. These anemias have been placed intothe three general categories of pure red-cell, hypoplastic, and aplastic anemias, in accordance with specific criteria. In pure red-cell anemia the failureof the bone marrow is confined to erythropoiesis, without simultaneous depression of granulocytes or platelets or their precursors. These patients survive long periods, provided repeated transfusions are administered to maintain normal blood levels. An adequate appraisal of therapy is not yet available because of lack of experience with large numbers of cases. However, spontaneous remissions have been observed, as well as recovery with steroids and following splenectomy. It was postulated that pure red-cell anemia and related hypoplastic anemias represent examples of congenital hematopoietic anomalies comparable to other somatic malformations originating from disturbances in embryonic and fetal life. The syndrome of “nonhemolyticanemia of the newborn” was described to include those infants who show a rapid fall of red cells and hemoglobin within the first days of life, without jaundice and erythroblastemia. The factors of incompatibility of blood groups, hemorrhage, hemolysis, and infection are not operative and the outlook based on a limited experience has been favorable. The syndrome probably represents an exaggeration of the aregenerative phase of erythropoiesis which characterizes the newborn period. The designation as “nonhemolytic anemia of the newborn” emphasizes its differentiation from erythroblastosis and probably coincides with some of the cases of anemia of the newborn reported before the discovery of the Rh factor. The mechanism of acute erythroblastopeniaand the aplastic crisis was reviewed in connection with their occurrence in hemolytic states such as sickle cell and spherocytic anemias. Under these circumstances the initial examination without knowledge of a pre-existing hemolytic anemia suggests a diagnosis of aplastic anemia. The bone marrow soon becomes reactive and the underlying condition is manifest. The temporary failure of erythropoiesisaccounts for the observation of protracted anemia in occasional cases of erythroblastosis. This inability to maintain normal blood levels may depend upon an inactive bone marrow as evidenced by a decreased erythroid cellular content. Two cases of chronic hypoplastic anemia were described which were suspected to be intermediate stages of aplastic anemia. In each instance the child was known to be allergic and susceptible to severe upper respiratory infections. The anemias resisted all hematinics except transfusion. Both children eventually recovered probably spontaneously although the effect of tonsillectomy in one and cortisone in the other could not be discounted. True aplastic anemia with an acellular bone marrow and pancytopenia is a rare occurrence in infancy and childhood. While search for a myelotoxic agent is usually unsuccessful, chloramphenicol has occasionally been associated with toxic hematopoietic effects. Since this drug has proved the agent of choice in specific clinical conditions, it is important to control its administration by frequent hematologic studies. Precautionary measures including blood and bone marrow examination have been outlined to detect reversible anemia and granulocytopenia. The possible suppressive effect of long-continued transfusions on erythropoiesis in any type of chronic anemia, nonhemolytic as well as hemolytic, may obscure the capacity for inherent blood formation and interfere with the appraisal of a specific blood picture. The optimum amount of blood to be administered and the interval between transfusions require serious consideration. Of major importance is to determine the actual need for transfusion, not in terms of a fixed hemoglobin value, but in relation to the clinical signs and symptoms manifested by the patient, with promise of their relief by this form of treatment. From the heterogeneous group ofhypoplastic-aplastic anemias, several well-defined clinical and hematological entities and distinctive blood responses have been chosen for review. These are normochromic and normocytic syndromes differentiated from other blood dyscrasias by the absence of active blood formation and their resistance to all forms of antianemia treatment except transfusion. These anemias have been placed intothe three general categories of pure red-cell, hypoplastic, and aplastic anemias, in accordance with specific criteria. In pure red-cell anemia the failureof the bone marrow is confined to erythropoiesis, without simultaneous depression of granulocytes or platelets or their precursors. These patients survive long periods, provided repeated transfusions are administered to maintain normal blood levels. An adequate appraisal of therapy is not yet available because of lack of experience with large numbers of cases. However, spontaneous remissions have been observed, as well as recovery with steroids and following splenectomy. It was postulated that pure red-cell anemia and related hypoplastic anemias represent examples of congenital hematopoietic anomalies comparable to other somatic malformations originating from disturbances in embryonic and fetal life. The syndrome of “nonhemolyticanemia of the newborn” was described to include those infants who show a rapid fall of red cells and hemoglobin within the first days of life, without jaundice and erythroblastemia. The factors of incompatibility of blood groups, hemorrhage, hemolysis, and infection are not operative and the outlook based on a limited experience has been favorable. The syndrome probably represents an exaggeration of the aregenerative phase of erythropoiesis which characterizes the newborn period. The designation as “nonhemolytic anemia of the newborn” emphasizes its differentiation from erythroblastosis and probably coincides with some of the cases of anemia of the newborn reported before the discovery of the Rh factor. The mechanism of acute erythroblastopeniaand the aplastic crisis was reviewed in connection with their occurrence in hemolytic states such as sickle cell and spherocytic anemias. Under these circumstances the initial examination without knowledge of a pre-existing hemolytic anemia suggests a diagnosis of aplastic anemia. The bone marrow soon becomes reactive and the underlying condition is manifest. The temporary failure of erythropoiesisaccounts for the observation of protracted anemia in occasional cases of erythroblastosis. This inability to maintain normal blood levels may depend upon an inactive bone marrow as evidenced by a decreased erythroid cellular content. Two cases of chronic hypoplastic anemia were described which were suspected to be intermediate stages of aplastic anemia. In each instance the child was known to be allergic and susceptible to severe upper respiratory infections. The anemias resisted all hematinics except transfusion. Both children eventually recovered probably spontaneously although the effect of tonsillectomy in one and cortisone in the other could not be discounted. True aplastic anemia with an acellular bone marrow and pancytopenia is a rare occurrence in infancy and childhood. While search for a myelotoxic agent is usually unsuccessful, chloramphenicol has occasionally been associated with toxic hematopoietic effects. Since this drug has proved the agent of choice in specific clinical conditions, it is important to control its administration by frequent hematologic studies. Precautionary measures including blood and bone marrow examination have been outlined to detect reversible anemia and granulocytopenia. The possible suppressive effect of long-continued transfusions on erythropoiesis in any type of chronic anemia, nonhemolytic as well as hemolytic, may obscure the capacity for inherent blood formation and interfere with the appraisal of a specific blood picture. The optimum amount of blood to be administered and the interval between transfusions require serious consideration. Of major importance is to determine the actual need for transfusion, not in terms of a fixed hemoglobin value, but in relation to the clinical signs and symptoms manifested by the patient, with promise of their relief by this form of treatment." @default.
- W1989454240 created "2016-06-24" @default.
- W1989454240 creator A5043135669 @default.
- W1989454240 date "1953-10-01" @default.
- W1989454240 modified "2023-09-26" @default.
- W1989454240 title "Hypoplastic and aplastic anemias of infancy and childhood: With a consideration of the syndrome of nonhemolytic anemia of the newborn" @default.
- W1989454240 cites W129954742 @default.
- W1989454240 cites W1506950205 @default.
- W1989454240 cites W1572478952 @default.
- W1989454240 cites W1673911836 @default.
- W1989454240 cites W1841559681 @default.
- W1989454240 cites W194536266 @default.
- W1989454240 cites W1972058702 @default.
- W1989454240 cites W1976011355 @default.
- W1989454240 cites W1997879685 @default.
- W1989454240 cites W2001060561 @default.
- W1989454240 cites W2001124121 @default.
- W1989454240 cites W2007185464 @default.
- W1989454240 cites W2008211250 @default.
- W1989454240 cites W2008551971 @default.
- W1989454240 cites W2012408966 @default.
- W1989454240 cites W2016207287 @default.
- W1989454240 cites W2021421654 @default.
- W1989454240 cites W2032725220 @default.
- W1989454240 cites W2040904893 @default.
- W1989454240 cites W2044797628 @default.
- W1989454240 cites W2046343112 @default.
- W1989454240 cites W2046797960 @default.
- W1989454240 cites W2049660240 @default.
- W1989454240 cites W2065127318 @default.
- W1989454240 cites W2065968611 @default.
- W1989454240 cites W2070107812 @default.
- W1989454240 cites W2077534211 @default.
- W1989454240 cites W2078353356 @default.
- W1989454240 cites W2078411092 @default.
- W1989454240 cites W2083121277 @default.
- W1989454240 cites W2085370359 @default.
- W1989454240 cites W2091585315 @default.
- W1989454240 cites W2094261958 @default.
- W1989454240 cites W2115168863 @default.
- W1989454240 cites W2137592091 @default.
- W1989454240 cites W2181510772 @default.
- W1989454240 cites W2183270233 @default.
- W1989454240 cites W2257697934 @default.
- W1989454240 cites W2295082831 @default.
- W1989454240 cites W2322146149 @default.
- W1989454240 cites W2327601475 @default.
- W1989454240 cites W2341163308 @default.
- W1989454240 cites W2400796136 @default.
- W1989454240 cites W2402375280 @default.
- W1989454240 cites W2411384345 @default.
- W1989454240 cites W2416138338 @default.
- W1989454240 cites W2421057973 @default.
- W1989454240 cites W2421554869 @default.
- W1989454240 cites W2990951799 @default.
- W1989454240 cites W4232578427 @default.
- W1989454240 cites W4244110265 @default.
- W1989454240 cites W4253535499 @default.
- W1989454240 doi "https://doi.org/10.1016/s0022-3476(53)80066-1" @default.
- W1989454240 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13097311" @default.
- W1989454240 hasPublicationYear "1953" @default.
- W1989454240 type Work @default.
- W1989454240 sameAs 1989454240 @default.
- W1989454240 citedByCount "31" @default.
- W1989454240 crossrefType "journal-article" @default.
- W1989454240 hasAuthorship W1989454240A5043135669 @default.
- W1989454240 hasConcept C126322002 @default.
- W1989454240 hasConcept C187212893 @default.
- W1989454240 hasConcept C203014093 @default.
- W1989454240 hasConcept C2778248108 @default.
- W1989454240 hasConcept C2780007613 @default.
- W1989454240 hasConcept C2781440808 @default.
- W1989454240 hasConcept C71924100 @default.
- W1989454240 hasConceptScore W1989454240C126322002 @default.
- W1989454240 hasConceptScore W1989454240C187212893 @default.
- W1989454240 hasConceptScore W1989454240C203014093 @default.
- W1989454240 hasConceptScore W1989454240C2778248108 @default.
- W1989454240 hasConceptScore W1989454240C2780007613 @default.
- W1989454240 hasConceptScore W1989454240C2781440808 @default.
- W1989454240 hasConceptScore W1989454240C71924100 @default.
- W1989454240 hasIssue "4" @default.
- W1989454240 hasLocation W19894542401 @default.
- W1989454240 hasLocation W19894542402 @default.
- W1989454240 hasOpenAccess W1989454240 @default.
- W1989454240 hasPrimaryLocation W19894542401 @default.
- W1989454240 hasRelatedWork W2135977549 @default.
- W1989454240 hasRelatedWork W2342084165 @default.
- W1989454240 hasRelatedWork W2374911868 @default.
- W1989454240 hasRelatedWork W2395129783 @default.
- W1989454240 hasRelatedWork W2396523293 @default.
- W1989454240 hasRelatedWork W2416791659 @default.
- W1989454240 hasRelatedWork W2901330354 @default.
- W1989454240 hasRelatedWork W3203700472 @default.
- W1989454240 hasRelatedWork W4205589580 @default.
- W1989454240 hasRelatedWork W4235609713 @default.
- W1989454240 hasVolume "43" @default.
- W1989454240 isParatext "false" @default.
- W1989454240 isRetracted "false" @default.